These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 24558672)

  • 1. Ponatinib pulled off market over safety issues.
    Dalzell MD
    Manag Care; 2013 Dec; 22(12):42-3. PubMed ID: 24558672
    [No Abstract]   [Full Text] [Related]  

  • 2. Marketing and commercial distribution of ponatinib suspended following FDA request.
    Small S
    Clin Adv Hematol Oncol; 2013 Dec; 11(12):808-9. PubMed ID: 25016626
    [No Abstract]   [Full Text] [Related]  

  • 3. Ariad suspends ponatinib sales.
    Cancer Discov; 2014 Jan; 4(1):6-7. PubMed ID: 24402926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The accelerated approval of oncologic drugs: lessons from ponatinib.
    Prasad V; Mailankody S
    JAMA; 2014 Jan 22-29; 311(4):353-4. PubMed ID: 24449310
    [No Abstract]   [Full Text] [Related]  

  • 5. Lamellar ichthyosis-like eruption associated with ponatinib.
    Örenay ÖM; Tamer F; Sarıfakıoğlu E; Yıldırım U
    Acta Dermatovenerol Alp Pannonica Adriat; 2016 Sep; 25(3):59-60. PubMed ID: 27695870
    [No Abstract]   [Full Text] [Related]  

  • 6. In brief: ponatinib (Inclusig) returns.
    Med Lett Drugs Ther; 2014 Jan; 56(1434):8. PubMed ID: 24457561
    [No Abstract]   [Full Text] [Related]  

  • 7. Ponatinib-induced pityriasiform, folliculocentric and ichthyosiform cutaneous toxicities.
    Alloo A; Sheu J; Butrynski JE; DeAngelo DJ; George S; Murphy GF; LeBoeuf NR
    Br J Dermatol; 2015 Aug; 173(2):574-7. PubMed ID: 25736577
    [No Abstract]   [Full Text] [Related]  

  • 8. Ponatinib-induced widespread ichthyosiform eruption.
    Derlino F; Barruscotti S; Zappasodi P; Brazzelli V; Vassallo C
    J Eur Acad Dermatol Venereol; 2017 Dec; 31(12):e519-e521. PubMed ID: 28557248
    [No Abstract]   [Full Text] [Related]  

  • 9. Ponatinib (Inclusig) marketing and sales suspended.
    Med Lett Drugs Ther; 2013 Nov; 55(1430):93. PubMed ID: 24276500
    [No Abstract]   [Full Text] [Related]  

  • 10. Pulmonary hypertension associated with ponatinib therapy.
    Quilot FM; Georges M; Favrolt N; Beltramo G; Foignot C; Grandvuillemin A; Montani D; Bonniaud P; Camus P
    Eur Respir J; 2016 Feb; 47(2):676-9. PubMed ID: 26743481
    [No Abstract]   [Full Text] [Related]  

  • 11. Ponatinib-induced atypical pityriasis rubra pilaris-like rash.
    Kamat D; Chatterjee D; Mahajan R
    Indian J Dermatol Venereol Leprol; 2020; 86(6):688-690. PubMed ID: 33159027
    [No Abstract]   [Full Text] [Related]  

  • 12. Ichthyosiform eruption and facial erythema secondary to ponatinib therapy.
    Munera-Campos M; Carrascosa JM; Quer A; Ferrándiz C
    J Dtsch Dermatol Ges; 2020 Jul; 18(7):743-747. PubMed ID: 32589336
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy and safety of low dose ponatinib in a case of Ph-positive acute lymphoblastic leukaemia.
    Marchesi F; Salvatorelli E; Renzi D; Mengarelli A; Minotti G; Menna P
    Br J Haematol; 2019 Oct; 187(1):e15-e17. PubMed ID: 31368155
    [No Abstract]   [Full Text] [Related]  

  • 14. Ponatinib-induced ichthyosiform drug eruption: insights into acquired ichthyosis.
    Xu H; Busam KJ; Mauro MJ; Markova A
    Dermatol Online J; 2017 Oct; 23(10):. PubMed ID: 29469781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ponatinib treatment promotes arterial thrombosis and hyperactive platelets.
    Merkulova A; Mitchell SC; Stavrou EX; Forbes GL; Schmaier AH
    Blood Adv; 2019 Aug; 3(15):2312-2316. PubMed ID: 31383636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ponatinib-induced lamellar ichthyosis-like drug eruption.
    Byrne N; Forde K; Mcdonald S; Malladi R; Chan S
    Eur J Dermatol; 2024 Apr; 34(2):236-238. PubMed ID: 38907571
    [No Abstract]   [Full Text] [Related]  

  • 17. Ponatinib-Associated Cardiac Tamponade.
    Lee JE; Ghous G; Tarar ZI; Zafar MU; Hassan Shoukat HM
    Am J Ther; 2021 Apr; 29(1):e148-e151. PubMed ID: 33929369
    [No Abstract]   [Full Text] [Related]  

  • 18. Real-life incidence of thrombotic events in leukemia patients treated with ponatinib.
    Nichols ED; Jabbour E; Jammal N; Chew S; Bryan J; Issa G; Garcia-Manero G; Sasaki K; DiPippo A; Kantarjian H
    Am J Hematol; 2022 Sep; 97(9):E350-E352. PubMed ID: 35759571
    [No Abstract]   [Full Text] [Related]  

  • 19. FDA OK's Iclusig's return to market.
    Cancer Discov; 2014 Feb; 4(2):138. PubMed ID: 24501288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ponatinib-induced ichthyosiform eruption].
    Sibaud V; Mouchel PL; Touhouche A; Huguet F; Bertoli S
    Ann Dermatol Venereol; 2019 Oct; 146(10):661-663. PubMed ID: 31540674
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.